Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer

Podobne zapisy

• Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study
  od: Peng, Jianhong, i wsp.
  Wydane: (2017)
• Prolonged Neutropenia After Neoadjuvant Radiation Therapy and Chemotherapy Using Oxaliplatin and Capecitabine for Rectal Cancer
  od: McFarland, Daniel C., i wsp.
  Wydane: (2011)
• Capecitabine and Oxaliplatin (XELOX) for the Treatment of Patients with Metastatic Gastric Cancer and Severe Liver Dysfunction
  od: Hwang, Seung Jae, i wsp.
  Wydane: (2006)
• Cetuximab combined with induction oxaliplatin and capecitabine, followed by neoadjuvant chemoradiation for locally advanced rectal cancer: SWOG 0713
  od: Leichman, Cynthia Gail, i wsp.
  Wydane: (2017)
• Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer
  od: Yang, Xiao-Hui, i wsp.
  Wydane: (2020)